Hormone Replacement Therapy
(asked on 5th November 2021) - View Source
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 4 November 2021 to Questions 65535 and 65536 on Hormone Replacement Therapy, what the nature of the issues was affecting the supplies of some HRT drugs and products.
This question was answered on 15th November 2021
Supply issues that have affected the availability of hormone replacement therapy (HRT) preparations include manufacturing issues, regulatory issues, problems accessing the raw pharmaceutical ingredient as well as commercial decisions made by some companies to divest these products.